These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The economic consequences of NSAID-induced gastrointestinal damage. de Pouvourville G; Tasch RF Eur J Rheumatol Inflamm; 1993; 13(1):33-40. PubMed ID: 7821337 [TBL] [Abstract][Full Text] [Related]
11. [Is there still a role for standard nonsteroidal antirheumatic agents?]. Laktasić-Zerjavić N Reumatizam; 2001; 48(2):24-6. PubMed ID: 12476744 [TBL] [Abstract][Full Text] [Related]
12. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease. Joshua FF; Oakley SP; Major GA Intern Med J; 2004 Apr; 34(4):153-61. PubMed ID: 15086694 [TBL] [Abstract][Full Text] [Related]
13. The use of NSAIDs in rheumatic disorders 2005: a global perspective. Kean WF; Buchanan WW Inflammopharmacology; 2005; 13(4):343-70. PubMed ID: 16354389 [TBL] [Abstract][Full Text] [Related]
14. [NSAIDs: a clinical pharmacological determination of their role in the drug treatment of rheumatic disorders]. van Riel PL Ned Tijdschr Geneeskd; 1988 Nov; 132(48):2187-92. PubMed ID: 3264601 [No Abstract] [Full Text] [Related]
15. The selection of a nonsteroidal antiinflammatory drug. Is there a difference? Willkens RF J Rheumatol Suppl; 1992 Nov; 36():9-12. PubMed ID: 1474545 [TBL] [Abstract][Full Text] [Related]
16. Conservative treatment of rheumatic disorders in the elderly. Mazanec DJ Geriatrics; 1991 May; 46(5):41-5. PubMed ID: 2029974 [TBL] [Abstract][Full Text] [Related]